• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Search Orphan Drug Designations and Approvals

  • Print
  • Share
  • E-mail
-
Generic Name: A therapeutic vaccine targeting the HPV16 E6/E7 proteins
Date Designated: 06/26/2020
Orphan Designation: Treatment of HPV16-positive cervical cancer
Orphan Designation Status: Designated
FDA Orphan Approval Status: Not FDA Approved for Orphan Indication
ISA Therapeutics BV
J.H. Oortweg 19
2333 CH Leiden
CH Leiden
Netherlands

The sponsor address listed is the last reported by the sponsor to OOPD.

*Exclusivity Protected Indications are shown for approvals from 01/01/2013 to the present.
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-
-